This study is testing a new system called FUSION to help control blood sugar in people with diabetes. It uses artificial intelligence (AI) to automatically adjust insulin, which is a hormone that lowers blood sugar, and dextrose, a type of sugar, to keep levels in a safe range (100-140 mg/dL) for 24 hours. This is especially important in intensive care units (ICUs) where keeping blood sugar steady is hard.

The study includes people aged 18-70 with type 1 or type 2 diabetes who have been managing their diabetes with a stable insulin routine. It takes place in a clinical research center and involves eating three meals and having blood sugar checked frequently to ensure safety. The system makes adjustments every 5-10 minutes based on readings from two glucose monitors.

Participants must not have certain health issues or have been in another study recently. Women of childbearing age must not be pregnant. The study aims to see if this new system can control blood sugar better than current methods.

• The study lasts 24 hours with continuous monitoring.
• Participants must have stable diabetes management and be between 18-70 years old.
• Regular blood sugar checks ensure safety during the study.